Facebook users shared a story claiming a Democratic Party-led "deep state assassination plot" involving the Pennsylvania U.S.
Macleods Pharmaceuticals Limited on Monday recalled one lot of the blood pressure medication losartan after discovering trace amounts of a probable carcinogen. The recalled 100 mg/25 mg losartan and ...
USA: Researchers have reported a potential risk of severe hypercalcemia when tirzepatide, a dual GIP and GLP-1 receptor agonist, is used in combination with chronic thiazide diuretics—particularly ...
An alternative methodology by capillary zone electrophoresis (CZE) is proposed for the determination of losartan potassium (LOS) associated with chlorthalidone (CTD) or hydrochlorothiazide (HCT) in ...
TAMPA, FL, March 18, 2025 (GLOBE NEWSWIRE) -- – SCIENTURE HOLDINGS, INC. NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced ...
Background:There is little evidence for treatment of morning hypertension, an independent risk for cardiovascular events. Thus, we compared the efficacy of losartan/hydrochlorothiazide combination and ...
Background: Cardiovascular events occur most frequently in the morning. Elevation of blood pressure (BP) in the early morning (morning hypertension) is characteristic feature of hypertension in the ...
Background: Arterial stiffness and medial vascular calcification, leading to isolated systolic blood pressure (BP), are major cardiovascular risk factors in patients with chronic kidney disease (CKD) ...
Losartan potassium and hydrochlorothiazide are often combined in pharmaceutical formulations for the treatment of hypertension. Therefore, the determination of these compounds in a single run is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results